Search

everythinglearnresearchcommunity

for

Search:↓

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Atopic dermatitis severity doesn't worsen during pregnancy for most women.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Mothers with atopic dermatitis have higher risks of pregnancy complications and their children are more likely to develop certain health conditions.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Platelet-rich plasma may help improve atopic dermatitis symptoms and quality of life.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Understanding the skin's bacteria and chemicals may help manage scalp issues in atopic dermatitis.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Filaggrin mutations are linked to atopic dermatitis and help explain how genetics and environment affect the disease.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.